| Dr Brandon Dale Greenwood, DDS | |
|
226 N 1100 E Ste D, American Fork, UT 84003-2054 | |
| (801) 756-6037 | |
| (801) 756-6088 |
| Full Name | Dr Brandon Dale Greenwood |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 226 N 1100 E Ste D, American Fork, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992889836 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 5158561-9922 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandon Dale Greenwood, DDS 226 N 1100 E Ste D, American Fork, UT 84003-2054 Ph: (801) 756-6037 | Dr Brandon Dale Greenwood, DDS 226 N 1100 E Ste D, American Fork, UT 84003-2054 Ph: (801) 756-6037 |
News Archive
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This applies to adults as well as to children and adolescents. This is the result of the final report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 19 April 2010.
Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.
Research from Taiwan suggests that combining trocar-guided transvaginal mesh surgery with a midurethral sling in the treatment of women with advanced pelvic organ prolapse could be an effective way to manage associated stress urinary incontinence.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
› Verified 7 days ago
Dr. Joseph Doyle Liddle, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 120 North Center, American Fork, UT 84003 Phone: 801-756-3377 | |
Dr. L. Craig Rosvall, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 224 S 1100 E, American Fork, UT 84003 Phone: 801-756-6581 Fax: 801-756-9318 | |
Dr. Greg G Pitts, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 9 N 1100 E, American Fork, UT 84003 Phone: 801-763-9000 Fax: 801-763-8300 | |
Dr. Steven Reed Braithwaite, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 218 N West State Rd, American Fork, UT 84003 Phone: 801-763-7737 Fax: 801-763-7757 | |
Dr. Scott A Tracy, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 321 E 300 N, American Fork, UT 84003 Phone: 801-756-0933 | |
Dr. Joel Brandon Richards, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 449 S 650 E, American Fork, UT 84003 Phone: 425-953-6334 | |
Dr. Boley Jacob Greenwood, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 226 N 1100 E, American Fork, UT 84003 Phone: 801-756-6037 Fax: 801-756-6088 |